Clinical Trial Update: IBI308 in Subjects With Advanced/Metastatic Solid Malignancies [Phase 1]

View source ↗

Summary

Phase 1 trial update for IBI308 in advanced/metastatic solid malignancies has been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Malignancies

Drugs mentioned

• IBI308 (IBI308)

Snippet

Sponsor: Innovent Biologics (Suzhou) Co. Ltd. | Conditions: Advanced/Metastatic Solid Malignancies | Phase 1 | Status: COMPLETED | Results posted: 2021-06-01